NATURE . COM {}

Matching Content Categories {📚}

• Science
• Education
• Health & Fitness

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌆 Monumental Traffic: 20M - 50M visitors per month


Based on our best estimate, this website will receive around 42,194,993 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}

Display Ads {🎯}

Direct Advertisers (10)

Reseller Advertisers (38)

How Much Does Nature.com Make? {💰}

Display Ads {🎯}

$531,700 per month
Our calculations suggest that Nature.com earns between $354,480 and $974,820 monthly online from display advertisements.

Keywords {🔍}

cells, irx, gefitinib, cancer, nanog, cell, expression, pcgr, fig, article, resistance, properties, google, scholar, china, lung, western, cas, stemlike, ohd, treatment, stem, blotting, protein, nsclc, tumor, signaling, combination, tgfβ, cytotoxicity, results, group, analysis, nature, egfrtki, increased, inhibited, stemness, experiments, transfected, usa, sirna, growth, celllike, treated, significantly, levels, assay, nanjing, viability,

Topics {✒️}

nature portfolio beta-catenin-mediated epithelial-mesenchymal transition vdr/plc-gamma1/tgf-beta1/pathway serum‐free opti‐mem media research groups privacy policy tgf-β/smad signaling-induced irx4 tgf-β1/smad3 signaling pathway tgf-β/smad signaling pathway28 nature small-molecule multi-kinase inhibitor20 advertising erk1/2-mzf1 signaling pathway reprints tgf-β1/smad3 signaling japan activating stat3/cxcl1 axis 2d3 signaling-induced decreases egfr-tyrosine kinase inhibitors small-cell lung cancer egfr-tki resistant cells irx4-mediated cancer stem potentiates cell death social media poor egfr-tki sensitivity inhibit egfr-tki resistance irx4-expressing cell lines nanog-mediated stem cell state key laboratory regulating egfr-tki resistance cd44+cd133+ pc-9/gr cells increase egfr-tki resistance high tgf-β1 levels irx-family genes participate egfr-mutant nsclc cells9 contract number hh20190622lhy-lv03 ventricular-specific progenitor cell multi-directional differentiation potential pnanog-luc reporter activity irx4+mouse embryonic cells original author tgf-β1 induced permissions sirna/plasmid‐lipid complexes lung cancer progression tyrosine kinase inhibitors 20 ng/ml tgf-β1 delayed development cell death dis pre-clinical models support

Questions {❓}

• How IRX4 controls gefitinib cytotoxicity?
• How to regulate IRX4-mediated cancer stem-like properties and gefitinib resistance?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:1,25-dihydroxyvitamin D3 signaling-induced decreases in IRX4 inhibits NANOG-mediated cancer stem-like properties and gefitinib resistance in NSCLC cells
         description:Recent studies have demonstrated that acquisition of cancer stem-like properties plays an essential role in promoting epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) resistance in non-small cell lung cancer (NSCLC); however, how to regulate cancer stem-like properties and EGFR-TKI resistance is largely unclear. In this study, we discovered that increased iroquois-class homeodomain protein 4 (IRX4) was related to gefitinib resistance in NSCLC cells. Knockdown of IRX4 inhibited cell proliferation, sphere formation, and the expression of CD133, ALDH1A1, NANOG, Sox2 and Notch1, and the transcriptional activity of NANOG promoter. IRX4 overexpression increased the protein level of NANOG and CD133 in PC-9 cells. Combination of knocking-down IRX4 with gefitinib increased cell apoptosis and decreased cell viability and the expression of p-EGFR and NANOG in PC-9/GR cells. IRX4 knockdown in a PC-9/GR xenograft tumor model inhibited tumor progression and the expression of NANOG and CD133 more effectively than single treatment alone. Knockdown of NANOG inhibited the expression of CD133 and restored gefitinib cytotoxicity, and NANOG overexpression-induced cancer stem-like properties and gefitinib resistance could be obviously reversed by knocking-down IRX4. Further, we found that 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) reduced obviously the expression of IRX4 and NANOG by inhibiting the activation of TGF-β1/Smad3 signaling pathway; moreover, combination of 1,25(OH)2D3 and gefitinib decreased cell viability and proliferation or tumor progression and the expression of IRX4 and NANOG compared with single treatment alone both in PC-9/GR cells and in a PC-9/GR xenograft tumor model. These results reveal that inhibition of IRX4-mediated cancer stem-like properties by regulating 1,25(OH)2D3 signaling may increase gefitinib cytotoxicity. Combination therapy of gefitinib and 1,25(OH)2D3 by targeting IRX4 and NANOG, could provide a promising strategy to improve gefitinib cytotoxicity.
         datePublished:2020-08-20T00:00:00Z
         dateModified:2020-08-20T00:00:00Z
         pageStart:1
         pageEnd:15
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1038/s41419-020-02908-w
         keywords:
            Cancer
            Cancer therapy
            Life Sciences
            general
            Biochemistry
            Cell Biology
            Immunology
            Cell Culture
            Antibodies
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig8_HTML.png
         isPartOf:
            name:Cell Death & Disease
            issn:
               2041-4889
            volumeNumber:11
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Zhirong Jia
               url:http://orcid.org/0000-0002-7381-5150
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yameng Zhang
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Aiwen Yan
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Meisa Wang
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Qiushuang Han
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kaiwei Wang
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jie Wang
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
                     name:the First Affiliated Hospital of Xinjiang Medical University
                     address:
                        name:Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chen Qiao
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
                     name:China Pharmaceutical University
                     address:
                        name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zhenzhen Pan
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chuansheng Chen
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Dong Hu
               affiliation:
                     name:Anhui University of Science and Technology
                     address:
                        name:Key Laboratory of Industrial Dust Prevention and Control & Occupational Safety and Health of the Ministry of Education, Medical School, Anhui University of Science and Technology, Huainan, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Xuansheng Ding
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
                     name:China Pharmaceutical University
                     address:
                        name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:1,25-dihydroxyvitamin D3 signaling-induced decreases in IRX4 inhibits NANOG-mediated cancer stem-like properties and gefitinib resistance in NSCLC cells
      description:Recent studies have demonstrated that acquisition of cancer stem-like properties plays an essential role in promoting epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) resistance in non-small cell lung cancer (NSCLC); however, how to regulate cancer stem-like properties and EGFR-TKI resistance is largely unclear. In this study, we discovered that increased iroquois-class homeodomain protein 4 (IRX4) was related to gefitinib resistance in NSCLC cells. Knockdown of IRX4 inhibited cell proliferation, sphere formation, and the expression of CD133, ALDH1A1, NANOG, Sox2 and Notch1, and the transcriptional activity of NANOG promoter. IRX4 overexpression increased the protein level of NANOG and CD133 in PC-9 cells. Combination of knocking-down IRX4 with gefitinib increased cell apoptosis and decreased cell viability and the expression of p-EGFR and NANOG in PC-9/GR cells. IRX4 knockdown in a PC-9/GR xenograft tumor model inhibited tumor progression and the expression of NANOG and CD133 more effectively than single treatment alone. Knockdown of NANOG inhibited the expression of CD133 and restored gefitinib cytotoxicity, and NANOG overexpression-induced cancer stem-like properties and gefitinib resistance could be obviously reversed by knocking-down IRX4. Further, we found that 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) reduced obviously the expression of IRX4 and NANOG by inhibiting the activation of TGF-β1/Smad3 signaling pathway; moreover, combination of 1,25(OH)2D3 and gefitinib decreased cell viability and proliferation or tumor progression and the expression of IRX4 and NANOG compared with single treatment alone both in PC-9/GR cells and in a PC-9/GR xenograft tumor model. These results reveal that inhibition of IRX4-mediated cancer stem-like properties by regulating 1,25(OH)2D3 signaling may increase gefitinib cytotoxicity. Combination therapy of gefitinib and 1,25(OH)2D3 by targeting IRX4 and NANOG, could provide a promising strategy to improve gefitinib cytotoxicity.
      datePublished:2020-08-20T00:00:00Z
      dateModified:2020-08-20T00:00:00Z
      pageStart:1
      pageEnd:15
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1038/s41419-020-02908-w
      keywords:
         Cancer
         Cancer therapy
         Life Sciences
         general
         Biochemistry
         Cell Biology
         Immunology
         Cell Culture
         Antibodies
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig8_HTML.png
      isPartOf:
         name:Cell Death & Disease
         issn:
            2041-4889
         volumeNumber:11
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Zhirong Jia
            url:http://orcid.org/0000-0002-7381-5150
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yameng Zhang
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Aiwen Yan
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Meisa Wang
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Qiushuang Han
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kaiwei Wang
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jie Wang
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
                  name:the First Affiliated Hospital of Xinjiang Medical University
                  address:
                     name:Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chen Qiao
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
                  name:China Pharmaceutical University
                  address:
                     name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zhenzhen Pan
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chuansheng Chen
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Dong Hu
            affiliation:
                  name:Anhui University of Science and Technology
                  address:
                     name:Key Laboratory of Industrial Dust Prevention and Control & Occupational Safety and Health of the Ministry of Education, Medical School, Anhui University of Science and Technology, Huainan, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Xuansheng Ding
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
                  name:China Pharmaceutical University
                  address:
                     name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cell Death & Disease
      issn:
         2041-4889
      volumeNumber:11
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:the First Affiliated Hospital of Xinjiang Medical University
      address:
         name:Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:Anhui University of Science and Technology
      address:
         name:Key Laboratory of Industrial Dust Prevention and Control & Occupational Safety and Health of the Ministry of Education, Medical School, Anhui University of Science and Technology, Huainan, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Zhirong Jia
      url:http://orcid.org/0000-0002-7381-5150
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Yameng Zhang
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Aiwen Yan
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Meisa Wang
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Qiushuang Han
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Kaiwei Wang
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Jie Wang
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
            name:the First Affiliated Hospital of Xinjiang Medical University
            address:
               name:Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
               type:PostalAddress
            type:Organization
      name:Chen Qiao
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
            name:China Pharmaceutical University
            address:
               name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Zhenzhen Pan
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Chuansheng Chen
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Dong Hu
      affiliation:
            name:Anhui University of Science and Technology
            address:
               name:Key Laboratory of Industrial Dust Prevention and Control & Occupational Safety and Health of the Ministry of Education, Medical School, Anhui University of Science and Technology, Huainan, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Xuansheng Ding
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
            name:China Pharmaceutical University
            address:
               name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:Key Laboratory of Industrial Dust Prevention and Control & Occupational Safety and Health of the Ministry of Education, Medical School, Anhui University of Science and Technology, Huainan, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China

Social Networks {👍}(1)

• https://twitter.com/cddpress

External Links {🔗}(114)

• What's the revenue for https://orcid.org/0000-0002-7381-5150?
• Financial intake of https://doi.org/10.1016%2FS0140-6736%2817%2933326-3
• How much money does http://scholar.google.com/scholar_lookup?&title=Global%20surveillance%20of%20trends%20in%20cancer%20survival%202000-14%20%28CONCORD-3%29%3A%20analysis%20of%20individual%20records%20for%2037%20513%20025%20patients%20diagnosed%20with%20one%20of%2018%20cancers%20from%20322%20population-based%20registries%20in%2071%20countries&journal=Lancet&doi=10.1016%2FS0140-6736%2817%2933326-3&volume=391&pages=1023-1075&publication_year=2018&author=Allemani%2CC generate?
• How much income is https://doi.org/10.1200%2FJCO.2012.45.3753 earning monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=Genotyping%20and%20genomic%20profiling%20of%20non-small-cell%20lung%20cancer%3A%20implications%20for%20current%20and%20future%20therapies&journal=J.%20Clin.%20Oncol.&doi=10.1200%2FJCO.2012.45.3753&volume=31&pages=1039-1049&publication_year=2013&author=Li%2CT&author=Kung%2CHJ&author=Mack%2CPC&author=Gandara%2CDR pull in monthly?
• What's the monthly money flow for https://doi.org/10.6004%2Fjnccn.2018.0062?
• How much does http://scholar.google.com/scholar_lookup?&title=NCCN%20guidelines%20insights%3A%20non-small%20cell%20lung%20cancer%2C%20Version%205.2018&journal=J.%20Natl%20Compr.%20Canc%20Netw.&doi=10.6004%2Fjnccn.2018.0062&volume=16&pages=807-821&publication_year=2018&author=Ettinger%2CDS pull in monthly?
• Profit of https://doi.org/10.1038%2Fcddis.2014.447
• How much revenue does http://scholar.google.com/scholar_lookup?&title=A%20novel%20antagonist%20to%20the%20inhibitors%20of%20apoptosis%20%28IAPs%29%20potentiates%20cell%20death%20in%20EGFR-overexpressing%20non-small-cell%20lung%20cancer%20cells&journal=Cell%20Death%20Dis.&doi=10.1038%2Fcddis.2014.447&volume=5&publication_year=2014&author=Lee%2CSH bring in?
• What's the monthly money flow for https://doi.org/10.2174%2F1574887114666181205155211?
• How much does http://scholar.google.com/scholar_lookup?&title=Advanced%20non-small%20cell%20lung%20cancer%20with%20activating%20epidermal%20growth%20factor%20receptor%20mutation%3A%20first%20line%20treatment%20and%20beyond&journal=Rev.%20Recent%20Clin.%20Trials&doi=10.2174%2F1574887114666181205155211&volume=14&pages=120-128&publication_year=2019&author=Rocco%2CD&author=Battiloro%2CC&author=Gravara%2CLD&author=Gridelli%2CC rake in every month?
• Learn about the earnings of https://link.springer.com/doi/10.1007/s40264-018-0772-x
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=Safety%20and%20tolerability%20of%20epidermal%20growth%20factor%20receptor%20%28EGFR%29%20tyrosine%20kinase%20inhibitors%20in%20oncology&journal=Drug%20Saf.&doi=10.1007%2Fs40264-018-0772-x&volume=42&pages=181-198&publication_year=2019&author=Shah%2CRR&author=Shah%2CDR
• https://doi.org/10.1016%2Fj.resinv.2018.09.001 income
• How much profit does http://scholar.google.com/scholar_lookup?&title=Resistance%20to%20molecularly%20targeted%20therapy%20in%20non-small-cell%20lung%20cancer&journal=Respir.%20Investig.&doi=10.1016%2Fj.resinv.2018.09.001&volume=57&pages=20-26&publication_year=2019&author=Asao%2CT&author=Takahashi%2CF&author=Takahashi%2CK generate?
• How much does https://doi.org/10.1111%2Fcas.12749 generate monthly?
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=Acquisition%20of%20cancer%20stem%20cell-like%20properties%20in%20non-small%20cell%20lung%20cancer%20with%20acquired%20resistance%20to%20afatinib&journal=Cancer%20Sci.&doi=10.1111%2Fcas.12749&volume=106&pages=1377-1384&publication_year=2015&author=Hashida%2CS
• https://doi.org/10.1038%2Fs41467-018-05626-2's revenue stream
• Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Notch3-dependent%20beta-catenin%20signaling%20mediates%20EGFR%20TKI%20drug%20persistence%20in%20EGFR%20mutant%20NSCLC&journal=Nat.%20Commun.&doi=10.1038%2Fs41467-018-05626-2&volume=9&publication_year=2018&author=Arasada%2CRR
• What's the monthly money flow for https://doi.org/10.1111%2Fcrj.12976?
• How much money does http://scholar.google.com/scholar_lookup?&title=CD146-mediated%20acquisition%20of%20stemness%20phenotype%20enhances%20tumour%20invasion%20and%20metastasis%20after%20EGFR-TKI%20resistance%20in%20lung%20cancer&journal=Clin.%20Respir.%20J.&doi=10.1111%2Fcrj.12976&volume=13&pages=23-33&publication_year=2019&author=Zhang%2CF generate?
• How much cash flow does https://doi.org/10.1158%2F0008-5472.CAN-12-4136 have monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=Acquired%20resistance%20to%20EGFR%20inhibitors%20is%20associated%20with%20a%20manifestation%20of%20stem%20cell-like%20properties%20in%20cancer%20cells&journal=Cancer%20Res.&doi=10.1158%2F0008-5472.CAN-12-4136&volume=73&pages=3051-3061&publication_year=2013&author=Shien%2CK earn?
• What is the earnings of https://doi.org/10.1016%2Fj.canlet.2018.07.020?
• http://scholar.google.com/scholar_lookup?&title=Genome-wide%20identification%20of%20transcription%20factors%20that%20are%20critical%20to%20non-small%20cell%20lung%20cancer&journal=Cancer%20Lett.&doi=10.1016%2Fj.canlet.2018.07.020&volume=434&pages=132-143&publication_year=2018&author=Zhang%2CDL's total income per month
• Explore the financials of https://link.springer.com/doi/10.1007/s00429-016-1326-6
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Expression%20patterns%20of%20Irx%20genes%20in%20the%20developing%20chick%20inner%20ear&journal=Brain%20Struct.%20Funct.&doi=10.1007%2Fs00429-016-1326-6&volume=222&pages=2071-2092&publication_year=2017&author=Cardena-Nunez%2CS
• Income figures for https://doi.org/10.1038%2Fncomms1301
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=An%20evolutionarily%20conserved%20three-dimensional%20structure%20in%20the%20vertebrate%20Irx%20clusters%20facilitates%20enhancer%20sharing%20and%20coregulation&journal=Nat.%20Commun.&doi=10.1038%2Fncomms1301&volume=2&publication_year=2011&author=Tena%2CJJ?
• What's the income generated by https://doi.org/10.1002%2Fstem.2486 each month?
• http://scholar.google.com/scholar_lookup?&title=Irx4%20marks%20a%20multipotent%2C%20ventricular-specific%20progenitor%20cell&journal=Stem%20Cells&doi=10.1002%2Fstem.2486&volume=34&pages=2875-2888&publication_year=2016&author=Nelson%2CDO's financial summary
• How much profit is https://doi.org/10.1016%2Fj.mcn.2008.11.003 making per month?
• How much income is http://scholar.google.com/scholar_lookup?&title=Formation%20of%20posterior%20cranial%20placode%20derivatives%20requires%20the%20Iroquois%20transcription%20factor%20irx4a&journal=Mol.%20Cell%20Neurosci.&doi=10.1016%2Fj.mcn.2008.11.003&volume=40&pages=328-337&publication_year=2009&author=Feijoo%2CCG&author=Saldias%2CMP&author=Paz%2CJF&author=Gomez-Skarmeta%2CJL&author=Allende%2CML earning monthly?
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22213310 generate?
• http://scholar.google.com/scholar_lookup?&title=Vitamin%20D%3A%20potential%20in%20the%20prevention%20and%20treatment%20of%20lung%20cancer&journal=Anticancer%20Res.&volume=32&pages=211-221&publication_year=2012&author=Norton%2CR&author=O%E2%80%99Connell%2CMA's financial summary
• What's the income of https://doi.org/10.1016%2Fj.jsbmb.2012.09.022?
• See how much http://scholar.google.com/scholar_lookup?&title=Differential%20response%20to%201alpha%2C25-dihydroxyvitamin%20D3%20%281alpha%2C25%28OH%292D3%29%20in%20non-small%20cell%20lung%20cancer%20cells%20with%20distinct%20oncogene%20mutations&journal=J.%20Steroid%20Biochem%20Mol.%20Biol.&doi=10.1016%2Fj.jsbmb.2012.09.022&volume=136&pages=264-270&publication_year=2013&author=Zhang%2CQ makes per month
• Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31002352's earnings
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=1alpha%2C25Dihydroxyvitamin%20D3%20restrains%20stem%20celllike%20properties%20of%20ovarian%20cancer%20cells%20by%20enhancing%20vitamin%20D%20receptor%20and%20suppressing%20CD44&journal=Oncol.%20Rep.&volume=41&pages=3393-3403&publication_year=2019&author=Ji%2CM&author=Liu%2CL&author=Hou%2CY&author=Li%2CB
• How much does https://doi.org/10.1016%2Fj.stem.2018.11.017 net monthly?
• Profit of http://scholar.google.com/scholar_lookup?&title=Targeting%20cancer%20stemness%20in%20the%20clinic%3A%20from%20hype%20to%20hope&journal=Cell%20Stem%20Cell&doi=10.1016%2Fj.stem.2018.11.017&volume=24&pages=25-40&publication_year=2019&author=Saygin%2CC&author=Matei%2CD&author=Majeti%2CR&author=Reizes%2CO&author=Lathia%2CJD
• Find out how much https://doi.org/10.1016%2Fj.canlet.2019.03.027 earns monthly
• How much does http://scholar.google.com/scholar_lookup?&title=Protective%20autophagy%20decreases%20osimertinib%20cytotoxicity%20through%20regulation%20of%20stem%20cell-like%20properties%20in%20lung%20cancer&journal=Cancer%20Lett.&doi=10.1016%2Fj.canlet.2019.03.027&volume=452&pages=191-202&publication_year=2019&author=Li%2CL make?
• What are the total earnings of https://doi.org/10.1038%2Fs41388-018-0589-1?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Cancer%20stem-like%20properties%20and%20gefitinib%20resistance%20are%20dependent%20on%20purine%20synthetic%20metabolism%20mediated%20by%20the%20mitochondrial%20enzyme%20MTHFD2&journal=Oncogene&doi=10.1038%2Fs41388-018-0589-1&volume=38&pages=2464-2481&publication_year=2019&author=Nishimura%2CT bring in?
• Income figures for https://doi.org/10.18632%2Foncotarget.3389
• Profit of http://scholar.google.com/scholar_lookup?&title=IL-8%20confers%20resistance%20to%20EGFR%20inhibitors%20by%20inducing%20stem%20cell%20properties%20in%20lung%20cancer&journal=Oncotarget&doi=10.18632%2Foncotarget.3389&volume=6&pages=10415-10431&publication_year=2015&author=Liu%2CYN
• How much profit does https://doi.org/10.1002%2Fstem.29 make?
• Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Functional%20evidence%20that%20the%20self-renewal%20gene%20NANOG%20regulates%20human%20tumor%20development&journal=Stem%20Cells&doi=10.1002%2Fstem.29&volume=27&pages=993-1005&publication_year=2009&author=Jeter%2CCR
• https://doi.org/10.1158%2F0008-5472.CAN-10-3320's total income per month
• Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=HIF%20induces%20human%20embryonic%20stem%20cell%20markers%20in%20cancer%20cells&journal=Cancer%20Res.&doi=10.1158%2F0008-5472.CAN-10-3320&volume=71&pages=4640-4652&publication_year=2011&author=Mathieu%2CJ
• How much does https://doi.org/10.1016%2Fj.suronc.2013.08.001 make?
• Profit of http://scholar.google.com/scholar_lookup?&title=Nanog%2C%20a%20novel%20prognostic%20marker%20for%20lung%20cancer&journal=Surg.%20Oncol.&doi=10.1016%2Fj.suronc.2013.08.001&volume=22&pages=224-229&publication_year=2013&author=Du%2CY
• Explore the financials of https://doi.org/10.1158%2F1078-0432.CCR-14-2437
• Earnings of http://scholar.google.com/scholar_lookup?&title=Activation%20of%20vitamin%20D%20receptor%20signaling%20downregulates%20the%20expression%20of%20nuclear%20FOXM1%20protein%20and%20suppresses%20pancreatic%20cancer%20cell%20stemness&journal=Clin.%20Cancer%20Res.&doi=10.1158%2F1078-0432.CCR-14-2437&volume=21&pages=844-853&publication_year=2015&author=Li%2CZ
• What's the monthly money flow for https://doi.org/10.1111%2Fcas.14237?
• How much does http://scholar.google.com/scholar_lookup?&title=Calcitriol%20inhibits%20migration%20and%20invasion%20of%20renal%20cell%20carcinoma%20cells%20by%20suppressing%20Smad2%2F3-%2C%20STAT3-%20and%20beta-catenin-mediated%20epithelial-mesenchymal%20transition&journal=Cancer%20Sci.&doi=10.1111%2Fcas.14237&volume=111&pages=59-71&publication_year=2020&author=Xu%2CS pull in?
• How much money does https://doi.org/10.1016%2Fj.molimm.2017.09.006 make?
• Profit of http://scholar.google.com/scholar_lookup?&title=1%2C25%28OH%292D3%20induces%20regulatory%20T%20cell%20differentiation%20by%20influencing%20the%20VDR%2FPLC-gamma1%2FTGF-beta1%2Fpathway&journal=Mol.%20Immunol.&doi=10.1016%2Fj.molimm.2017.09.006&volume=91&pages=156-164&publication_year=2017&author=Zhou%2CQ
• What's the financial outcome of https://doi.org/10.1038%2Fs41556-018-0062-y?
• Discover the revenue of http://scholar.google.com/scholar_lookup?&title=PSPC1%20mediates%20TGF-beta1%20autocrine%20signalling%20and%20Smad2%2F3%20target%20switching%20to%20promote%20EMT%2C%20stemness%20and%20metastasis&journal=Nat.%20Cell%20Biol.&doi=10.1038%2Fs41556-018-0062-y&volume=20&pages=479-491&publication_year=2018&author=Yeh%2CHW
• How much income does https://doi.org/10.1111%2Ffebs.14162 have?
• http://scholar.google.com/scholar_lookup?&title=TGF-beta1-induced%20CK17%20enhances%20cancer%20stem%20cell-like%20properties%20rather%20than%20EMT%20in%20promoting%20cervical%20cancer%20metastasis%20via%20the%20ERK1%2F2-MZF1%20signaling%20pathway&journal=FEBS%20J.&doi=10.1111%2Ffebs.14162&volume=284&pages=3000-3017&publication_year=2017&author=Wu%2CL's revenue stream
• What's the financial outcome of https://doi.org/10.1016%2Fj.biopha.2015.10.018?
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=TGF-beta1%20induces%20erlotinib%20resistance%20in%20non-small%20cell%20lung%20cancer%20by%20down-regulating%20PTEN&journal=Biomed.%20Pharmacother.&doi=10.1016%2Fj.biopha.2015.10.018&volume=77&pages=1-6&publication_year=2016&author=Shen%2CH?
• https://doi.org/10.1158%2F1535-7163.MCT-13-0448 income
• How profitable is http://scholar.google.com/scholar_lookup?&title=MiR-134%2F487b%2F655%20cluster%20regulates%20TGF-beta-induced%20epithelial-mesenchymal%20transition%20and%20drug%20resistance%20to%20gefitinib%20by%20targeting%20MAGI2%20in%20lung%20adenocarcinoma%20cells&journal=Mol.%20Cancer%20Ther.&doi=10.1158%2F1535-7163.MCT-13-0448&volume=13&pages=444-453&publication_year=2014&author=Kitamura%2CK?
• Profit of https://doi.org/10.1038%2Fncomms1880
• What's the profit of http://scholar.google.com/scholar_lookup?&title=Loss-of-function%20of%20inositol%20polyphosphate-4-phosphatase%20reversibly%20increases%20the%20severity%20of%20allergic%20airway%20inflammation&journal=Nat.%20Commun.&doi=10.1038%2Fncomms1880&volume=3&publication_year=2012&author=Aich%2CJ&author=Mabalirajan%2CU&author=Ahmad%2CT&author=Agrawal%2CA&author=Ghosh%2CB?
• Get to know what's the income of https://doi.org/10.1073%2Fpnas.1009472107
• How much profit does http://scholar.google.com/scholar_lookup?&title=TGF-beta%20IL-6%20axis%20mediates%20selective%20and%20adaptive%20mechanisms%20of%20resistance%20to%20molecular%20targeted%20therapy%20in%20lung%20cancer&journal=Proc.%20Natl%20Acad.%20Sci.%20USA&doi=10.1073%2Fpnas.1009472107&volume=107&pages=15535-15540&publication_year=2010&author=Yao%2CZ make?
• Income figures for https://link.springer.com/doi/10.1186/s13046-019-1120-4
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Co-administration%20of%2020%28S%29-protopanaxatriol%20%28g-PPT%29%20and%20EGFR-TKI%20overcomes%20EGFR-TKI%20resistance%20by%20decreasing%20SCD1%20induced%20lipid%20accumulation%20in%20non-small%20cell%20lung%20cancer&journal=J.%20Exp.%20Clin.%20Cancer%20Res&doi=10.1186%2Fs13046-019-1120-4&volume=38&publication_year=2019&author=Huang%2CQ generate?
• How much does https://link.springer.com/doi/10.1186/s13046-018-0894-0 bring in each month?
• How much does http://scholar.google.com/scholar_lookup?&title=FOXC1%20induces%20cancer%20stem%20cell-like%20properties%20through%20upregulation%20of%20beta-catenin%20in%20NSCLC&journal=J.%20Exp.%20Clin.%20Cancer%20Res.&doi=10.1186%2Fs13046-018-0894-0&volume=37&publication_year=2018&author=Cao%2CS earn?
• https://doi.org/10.1158%2F1078-0432.CCR-13-2613's total income per month
• How much does http://scholar.google.com/scholar_lookup?&title=Metformin%20sensitizes%20EGFR-TKI-resistant%20human%20lung%20cancer%20cells%20in%20vitro%20and%20in%20vivo%20through%20inhibition%20of%20IL-6%20signaling%20and%20EMT%20reversal&journal=Clin.%20Cancer%20Res.&doi=10.1158%2F1078-0432.CCR-13-2613&volume=20&pages=2714-2726&publication_year=2014&author=Li%2CL bring in each month?
• Check the income stats for https://citation-needed.springer.com/v2/references/10.1038/s41419-020-02908-w?format=refman&flavour=references
• What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Zhirong%20Jia?
• Profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Zhirong%20Jia%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yameng%20Zhang earn?
• Earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yameng%20Zhang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Aiwen%20Yan?
• How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Aiwen%20Yan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
• Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Meisa%20Wang
• How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Meisa%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
• What is the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Qiushuang%20Han?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Qiushuang%20Han%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in monthly?
• Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kaiwei%20Wang earns monthly
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kaiwei%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
• What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jie%20Wang?
• What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jie%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Chen%20Qiao's revenue stream
• What is the monthly revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Chen%20Qiao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Zhenzhen%20Pan generate?
• How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Zhenzhen%20Pan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Chuansheng%20Chen
• How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Chuansheng%20Chen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
• Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Dong%20Hu
• Get to know what's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Dong%20Hu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What's https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xuansheng%20Ding's gross income?
• What's the monthly money flow for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xuansheng%20Ding%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's the revenue for http://creativecommons.org/licenses/by/4.0/?
• Learn about the earnings of https://s100.copyright.com/AppDispatchServlet?title=1%2C25-dihydroxyvitamin%20D3%20signaling-induced%20decreases%20in%20IRX4%20inhibits%20NANOG-mediated%20cancer%20stem-like%20properties%20and%20gefitinib%20resistance%20in%20NSCLC%20cells&author=Zhirong%20Jia%20et%20al&contentID=10.1038%2Fs41419-020-02908-w©right=The%20Author%28s%29&publication=2041-4889&publicationDate=2020-08-20&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY
• Get to know https://crossmark.crossref.org/dialog/?doi=10.1038/s41419-020-02908-w's earnings
• How much money does https://citation-needed.springer.com/v2/references/10.1038/s41419-020-02908-w?format=refman&flavour=citation make?
• How much revenue does https://doi.org/10.1007/s10555-024-10171-0 bring in?
• Financial intake of https://doi.org/10.1186/s12943-023-01877-w
• How much does https://doi.org/10.1007/s12032-023-02210-7 generate monthly?
• Income figures for https://doi.org/10.1038/s41420-022-00918-5
• How much does https://www.protocols.io/ net monthly?
• How much does https://www.natureindex.com/ pull in monthly?
• Earnings of http://www.naturechina.com
• How much profit is https://www.natureasia.com/ja-jp making per month?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Prism.js
• Zoom.js

Emails and Hosting {✉️}

Mail Servers:

• mxa-002c5801.gslb.pphosted.com
• mxb-002c5801.gslb.pphosted.com

Name Servers:

• pdns1.ultradns.net
• pdns2.ultradns.net
• pdns3.ultradns.org
• pdns4.ultradns.org
• pdns5.ultradns.info
• pdns6.ultradns.co.uk

CDN Services {📦}

• Crossref